chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Extreme fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FATIGUE (Extreme fatigue) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced FATIGUE (Extreme fatigue). On 03-Mar-2021, FATIGUE (Extreme fatigue) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medications not reported. No treatment information provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-067195 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-067195:Cross linked with dose 2
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: pain in the arm returned in his left side; after effect which felt like he was punched in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm returned in his left side) and VACCINATION SITE PAIN (after effect which felt like he was punched in the left arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE PAIN (after effect which felt like he was punched in the left arm). On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in the arm returned in his left side). At the time of the report, PAIN IN EXTREMITY (pain in the arm returned in his left side) outcome was unknown and VACCINATION SITE PAIN (after effect which felt like he was punched in the left arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication not provided. Treatment medication not provided.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Chills, Cough, Pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), COUGH, SPUTUM DISCOLOURED (yellow phlegm), ANOSMIA (perceives no smell) and AGEUSIA (no perceives no taste) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PAIN (body aches), COUGH, SPUTUM DISCOLOURED (yellow phlegm), PYREXIA (a slight fever) and CHILLS. On 05-Apr-2021, the patient experienced ANOSMIA (perceives no smell) and AGEUSIA (perceives no taste). On 04-Apr-2021, PAIN (body aches), COUGH, SPUTUM DISCOLOURED (yellow phlegm), PYREXIA (a slight fever) and CHILLS had resolved. At the time of the report, ANOSMIA (perceives no smell) and AGEUSIA (perceives no taste) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication nor provided. Treatment medication not provided.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Sputum discoloured
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), COUGH, SPUTUM DISCOLOURED (yellow phlegm), ANOSMIA (perceives no smell) and AGEUSIA (no perceives no taste) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PAIN (body aches), COUGH, SPUTUM DISCOLOURED (yellow phlegm), PYREXIA (a slight fever) and CHILLS. On 05-Apr-2021, the patient experienced ANOSMIA (perceives no smell) and AGEUSIA (perceives no taste). On 04-Apr-2021, PAIN (body aches), COUGH, SPUTUM DISCOLOURED (yellow phlegm), PYREXIA (a slight fever) and CHILLS had resolved. At the time of the report, ANOSMIA (perceives no smell) and AGEUSIA (perceives no taste) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication nor provided. Treatment medication not provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: it itches a little; injection site is still swollen; it is a little sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (it itches a little), VACCINATION SITE SWELLING (injection site is still swollen) and VACCINATION SITE PAIN (it is a little sore) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 immunisation.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (it itches a little), VACCINATION SITE SWELLING (injection site is still swollen) and VACCINATION SITE PAIN (it is a little sore). At the time of the report, VACCINATION SITE PRURITUS (it itches a little), VACCINATION SITE SWELLING (injection site is still swollen) and VACCINATION SITE PAIN (it is a little sore) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.   No treatment was reported for the events.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Muscular weakness, Myalgia
Clinical narrative: weakness of the muscle in the upper arm (cannot lift arm over her head); discomfort on her hips down to her knees; soreness of the muscle in the upper arm; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (weakness of the muscle in the upper arm (cannot lift arm over her head)), DISCOMFORT (discomfort on her hips down to her knees) and MYALGIA (soreness of the muscle in the upper arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced MUSCULAR WEAKNESS (weakness of the muscle in the upper arm (cannot lift arm over her head)) and DISCOMFORT (discomfort on her hips down to her knees). 19-Mar-2021, the patient experienced MYALGIA (soreness of the muscle in the upper arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MUSCULAR WEAKNESS (weakness of the muscle in the upper arm (cannot lift arm over her head)), DISCOMFORT (discomfort on her hips down to her knees) and MYALGIA (soreness of the muscle in the upper arm) had not resolved.            This case was linked to MODERNATX, INC.-MOD-2021-067210 (E2B Linked Report).; Sender's Comments: MODERNATX, INC.-MOD-2021-067210:1st dose
Sex: F
Vaccine: COVID19
Symptoms: Energy increased, Hypersensitivity, Inappropriate schedule of product administration, Oropharyngeal pain, Taste disorder
Clinical narrative: Basic allergies; Had more energy first four hours after the shot; Second dose scheduled at day 43, patient has not received second dose yet; sore throat; Bad taste in her mouth; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (Bad taste in her mouth), ENERGY INCREASED (Had more energy first four hours after the shot), OROPHARYNGEAL PAIN (Sore throat), HYPERSENSITIVITY (Basic allergies) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose scheduled at day 43, patient has not received second dose yet) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.  Concomitant products included PANTOPRAZOLE and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced TASTE DISORDER (Bad taste in her mouth) and ENERGY INCREASED (Had more energy first four hours after the shot). On 02-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat) and HYPERSENSITIVITY (Basic allergies). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose scheduled at day 43, patient has not received second dose yet). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) ongoing since an unknown date at an unspecified dose and frequency and FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) at an unspecified dose and frequency. On 09-Mar-2021, ENERGY INCREASED (Had more energy first four hours after the shot) had resolved. On 23-Mar-2021, TASTE DISORDER (Bad taste in her mouth) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Sore throat) and HYPERSENSITIVITY (Basic allergies) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose scheduled at day 43, patient has not received second dose yet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site warmth, Pruritus, Urticaria
Clinical narrative: Hives; Itching; Area still has redness; warm to the touch; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of URTICARIA (Hives), PRURITUS (Itching), INJECTION SITE ERYTHEMA (Area still has redness) and INJECTION SITE WARMTH (warm to the touch) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Drug allergy (reacts to gelatin in capsules). Concurrent medical conditions included Drug allergy (reacting to the gylcerol from the vaccine). Concomitant products included METOPROLOL, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), RAMIPRIL, METFORMIN, CALCIUM CITRATE, ERGOCALCIFEROL (CAL CITRATE PLUS VITAMIN D) and SITAGLIPTIN (JANUVIA [SITAGLIPTIN]) for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced URTICARIA (Hives), PRURITUS (Itching), INJECTION SITE ERYTHEMA (Area still has redness) and INJECTION SITE WARMTH (warm to the touch). At the time of the report, URTICARIA (Hives), PRURITUS (Itching), INJECTION SITE ERYTHEMA (Area still has redness) and INJECTION SITE WARMTH (warm to the touch) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Pyrexia
Clinical narrative: Nausea; low grade fever; cold chills; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), PYREXIA (low grade fever) and CHILLS (cold chills) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018AZ1A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Multiple sclerosis and Celiac disease.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced NAUSEA (Nausea), PYREXIA (low grade fever) and CHILLS (cold chills). On 27-Feb-2021, NAUSEA (Nausea), PYREXIA (low grade fever) and CHILLS (cold chills) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: patient reported that she had a red circular spot that was a little bigger than a size of a quarter at; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (patient reported that she had a red circular spot that was a little bigger than a size of a quarter at) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included CALCIUM PANTOTHENATE, FOLIC ACID, VITAMINS NOS (MULTI-VITAMINS VITAFIT) for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (patient reported that she had a red circular spot that was a little bigger than a size of a quarter at). At the time of the report, VACCINATION SITE ERYTHEMA (patient reported that she had a red circular spot that was a little bigger than a size of a quarter at) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID-19; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of COVID-19 (COVID-19) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Apr-2021, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication not received.  Treatment medication not received.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow up document received on 28-JUN-2021- No new information
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Muscle tightness, Neck pain, Paraesthesia, SARS-CoV-2 test
Clinical narrative: neck pain like she had during the the vaccine; headache comes and goes; tingling in her head; felt tight neck; swelling in her neck; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in her head), MUSCLE TIGHTNESS (felt tight neck), SWELLING (swelling in her neck), NECK PAIN (neck pain like she had during the the vaccine) and HEADACHE (headache comes and goes) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041M204) for COVID-19 vaccination.     The patient's past medical history included Cervical disc herniation (She had bulging disk in her neck pain in the back of her neck.). Concurrent medical conditions included Hashimoto's disease, Celiac disease, Penicillin allergy, Allergic reaction to drug (morphine), Drug allergy (betadine) and Drug allergy (naproxen). Concomitant products included ESTRADIOL from 08-Jan-2014 to an unknown date for Estrogen replacement therapy, LEVOTHYROXINE SODIUM (SYNTHROID) from 08-Jan-2013 to an unknown date for Hashimoto's disease, DOXYCYCLINE for Rosacea.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced PARAESTHESIA (tingling in her head), MUSCLE TIGHTNESS (felt tight neck), SWELLING (swelling in her neck) and HEADACHE (headache comes and goes). On 31-Mar-2021, the patient experienced NECK PAIN (neck pain like she had during the the vaccine). The patient was treated with PREDNISONE at an unspecified dose and frequency and CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (tingling in her head), MUSCLE TIGHTNESS (felt tight neck), SWELLING (swelling in her neck), NECK PAIN (neck pain like she had during the the vaccine) and HEADACHE (headache comes and goes) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included Multivitamins.   This case was linked to MOD-2021-133379 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: follow up received on 16-May-2021  contains significant information allergic condition, patient demographic, concomitant medication, lab data.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: neck pain like she had during the the vaccine; headache comes and goes; tingling in her head; felt tight neck; swelling in her neck; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in her head), MUSCLE TIGHTNESS (felt tight neck), SWELLING (swelling in her neck), NECK PAIN (neck pain like she had during the the vaccine) and HEADACHE (headache comes and goes) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041M204) for COVID-19 vaccination.     The patient's past medical history included Cervical disc herniation (She had bulging disk in her neck pain in the back of her neck.). Concurrent medical conditions included Hashimoto's disease, Celiac disease, Penicillin allergy, Allergic reaction to drug (morphine), Drug allergy (betadine) and Drug allergy (naproxen). Concomitant products included ESTRADIOL from 08-Jan-2014 to an unknown date for Estrogen replacement therapy, LEVOTHYROXINE SODIUM (SYNTHROID) from 08-Jan-2013 to an unknown date for Hashimoto's disease, DOXYCYCLINE for Rosacea.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced PARAESTHESIA (tingling in her head), MUSCLE TIGHTNESS (felt tight neck), SWELLING (swelling in her neck) and HEADACHE (headache comes and goes). On 31-Mar-2021, the patient experienced NECK PAIN (neck pain like she had during the the vaccine). The patient was treated with PREDNISONE at an unspecified dose and frequency and CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (tingling in her head), MUSCLE TIGHTNESS (felt tight neck), SWELLING (swelling in her neck), NECK PAIN (neck pain like she had during the the vaccine) and HEADACHE (headache comes and goes) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included Multivitamins.   This case was linked to MOD-2021-133379 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: follow up received on 16-May-2021  contains significant information allergic condition, patient demographic, concomitant medication, lab data.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness started two days ago and is ongoing.; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness started two days ago and is ongoing.) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included NAPHAZOLINE HYDROCHLORIDE (EYE DROPS [NAPHAZOLINE HYDROCHLORIDE]) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced DIZZINESS (Dizziness started two days ago and is ongoing.). At the time of the report, DIZZINESS (Dizziness started two days ago and is ongoing.) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information were reported.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: arm pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain) and HEADACHE (Headache) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 006B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced HEADACHE (Headache). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain). At the time of the report, PAIN IN EXTREMITY (arm pain) had resolved and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication not provided. Treatment medication not provided   This case was linked to US-MODERNATX, INC.-MOD-2021-067245 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-067245:crosslinked with dose 2
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Pain, Pyrexia
Clinical narrative: Fever; Achy; Did not eat anything much, was not hungry; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), PAIN (Achy) and DECREASED APPETITE (Did not eat anything much, was not hungry) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concomitant products included VITAMINS NOS and PAROXETINE for an unknown indication.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PYREXIA (Fever), PAIN (Achy) and DECREASED APPETITE (Did not eat anything much, was not hungry). At the time of the report, PYREXIA (Fever), PAIN (Achy) and DECREASED APPETITE (Did not eat anything much, was not hungry) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   The events started 10 to 12 hours after receiving the first dose and lasted for four days. The patient states that it felt like she had COVID-19 again. She was wondering if she should take the second dose. The events were treated with Tylenol.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itchy; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 29L29 and 014M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Medical History reported).   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced PRURITUS (Itchy). On 05-Apr-2021, PRURITUS (Itchy) had resolved.            This case was linked to US-MODERNATX, INC.-MOD-2021-067209 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-067209:1st dose
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Rash pruritic
Clinical narrative: Sore arm; Developed a rash on her upper body, which is still itchy; Felt itchy; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Felt itchy), PAIN IN EXTREMITY (Sore arm) and RASH PRURITIC (Developed a rash on her upper body, which is still itchy) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00BB21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PRURITUS (Felt itchy) and RASH PRURITIC (Developed a rash on her upper body, which is still itchy). On 23-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PRURITUS (Felt itchy) and RASH PRURITIC (Developed a rash on her upper body, which is still itchy) had not resolved and PAIN IN EXTREMITY (Sore arm) had resolved   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Lethargy, Migraine, Movement disorder
Clinical narrative: Lethargy; Could not get up; Could not move; Fatigue; Migraine that hasn't gone away since; The injection site had a lump; A large area swollen up; Feverish; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargy), ASTHENIA (Could not get up), MOVEMENT DISORDER (Could not move), FATIGUE (Fatigue) and MIGRAINE (Migraine that hasn't gone away since) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Corneal staining.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced LETHARGY (Lethargy), ASTHENIA (Could not get up), MOVEMENT DISORDER (Could not move), FATIGUE (Fatigue), MIGRAINE (Migraine that hasn't gone away since), VACCINATION SITE MASS (The injection site had a lump), SWELLING (A large area swollen up) and PYREXIA (Feverish). At the time of the report, LETHARGY (Lethargy), ASTHENIA (Could not get up), MOVEMENT DISORDER (Could not move), FATIGUE (Fatigue), VACCINATION SITE MASS (The injection site had a lump), SWELLING (A large area swollen up) and PYREXIA (Feverish) outcome was unknown and MIGRAINE (Migraine that hasn't gone away since) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient took Benadryl and put an ice pack as a treatment for the events.  Her concomitant medications include: Hormone shots.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Swelling, Vaccination site mass
Clinical narrative: Lethargy; Could not get up; Could not move; Fatigue; Migraine that hasn't gone away since; The injection site had a lump; A large area swollen up; Feverish; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargy), ASTHENIA (Could not get up), MOVEMENT DISORDER (Could not move), FATIGUE (Fatigue) and MIGRAINE (Migraine that hasn't gone away since) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Corneal staining.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced LETHARGY (Lethargy), ASTHENIA (Could not get up), MOVEMENT DISORDER (Could not move), FATIGUE (Fatigue), MIGRAINE (Migraine that hasn't gone away since), VACCINATION SITE MASS (The injection site had a lump), SWELLING (A large area swollen up) and PYREXIA (Feverish). At the time of the report, LETHARGY (Lethargy), ASTHENIA (Could not get up), MOVEMENT DISORDER (Could not move), FATIGUE (Fatigue), VACCINATION SITE MASS (The injection site had a lump), SWELLING (A large area swollen up) and PYREXIA (Feverish) outcome was unknown and MIGRAINE (Migraine that hasn't gone away since) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient took Benadryl and put an ice pack as a treatment for the events.  Her concomitant medications include: Hormone shots.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pyrexia, Skin warm
Clinical narrative: Slightly feverish; Had a red spot on her arm that is about the size of a baseball; Red spot is generating heat; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Slightly feverish), ERYTHEMA (Had a red spot on her arm that is about the size of a baseball) and SKIN WARM (Red spot is generating heat) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PYREXIA (Slightly feverish), ERYTHEMA (Had a red spot on her arm that is about the size of a baseball) and SKIN WARM (Red spot is generating heat). The patient was treated with IBUPROFEN (oral) at an unspecified dose and frequency. On 02-Apr-2021, PYREXIA (Slightly feverish) had resolved. At the time of the report, ERYTHEMA (Had a red spot on her arm that is about the size of a baseball) and SKIN WARM (Red spot is generating heat) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The fever subsided after 24 hours, but the other side effects are still present and have not begun to subside. Treatment for the events:  ice pack.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Throat tightness
Clinical narrative: Throat felt tight; Softball size swelling at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (Throat felt tight) and INJECTION SITE SWELLING (Softball size swelling at site of injection) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug hypersensitivity (Codeine) and Environmental allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced THROAT TIGHTNESS (Throat felt tight) and INJECTION SITE SWELLING (Softball size swelling at site of injection). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. In March 2021, THROAT TIGHTNESS (Throat felt tight) and INJECTION SITE SWELLING (Softball size swelling at site of injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Consumer reported that Benadryl resolved her symptoms.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Injection site erythema, Injection site pruritus, Injection site swelling, Nausea
Clinical narrative: Dizziness; Rash on her injection arm that extended from her shoulder to wrist; Injection site is red; Injection site is swollen; Injection site is very itchy; Low-grade fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), RASH (Rash on her injection arm that extended from her shoulder to wrist), INJECTION SITE ERYTHEMA (Injection site is red), INJECTION SITE SWELLING (Injection site is swollen) and INJECTION SITE PRURITUS (Injection site is very itchy) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced DIZZINESS (Dizziness), RASH (Rash on her injection arm that extended from her shoulder to wrist), INJECTION SITE ERYTHEMA (Injection site is red), INJECTION SITE SWELLING (Injection site is swollen), INJECTION SITE PRURITUS (Injection site is very itchy), PYREXIA (Low-grade fever) and NAUSEA (Nausea). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 05-Apr-2021, DIZZINESS (Dizziness), PYREXIA (Low-grade fever) and NAUSEA (Nausea) had resolved. At the time of the report, RASH (Rash on her injection arm that extended from her shoulder to wrist), INJECTION SITE ERYTHEMA (Injection site is red), INJECTION SITE SWELLING (Injection site is swollen) and INJECTION SITE PRURITUS (Injection site is very itchy) outcome was unknown.            No concomitant medication was reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash
Clinical narrative: Dizziness; Rash on her injection arm that extended from her shoulder to wrist; Injection site is red; Injection site is swollen; Injection site is very itchy; Low-grade fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), RASH (Rash on her injection arm that extended from her shoulder to wrist), INJECTION SITE ERYTHEMA (Injection site is red), INJECTION SITE SWELLING (Injection site is swollen) and INJECTION SITE PRURITUS (Injection site is very itchy) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced DIZZINESS (Dizziness), RASH (Rash on her injection arm that extended from her shoulder to wrist), INJECTION SITE ERYTHEMA (Injection site is red), INJECTION SITE SWELLING (Injection site is swollen), INJECTION SITE PRURITUS (Injection site is very itchy), PYREXIA (Low-grade fever) and NAUSEA (Nausea). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 05-Apr-2021, DIZZINESS (Dizziness), PYREXIA (Low-grade fever) and NAUSEA (Nausea) had resolved. At the time of the report, RASH (Rash on her injection arm that extended from her shoulder to wrist), INJECTION SITE ERYTHEMA (Injection site is red), INJECTION SITE SWELLING (Injection site is swollen) and INJECTION SITE PRURITUS (Injection site is very itchy) outcome was unknown.            No concomitant medication was reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: covid arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (covid arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history provided).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (covid arm). At the time of the report, VACCINATION SITE REACTION (covid arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No medical history and concomitant medications were provided.  No treatment information provided
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: received an accidental 3rd dose; This spontaneous case was reported by a pharmacist and describes the occurrence of EXTRA DOSE ADMINISTERED (received an accidental 3rd dose) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Apr-2021 at 10:39 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXTRA DOSE ADMINISTERED (received an accidental 3rd dose). On 03-Apr-2021, EXTRA DOSE ADMINISTERED (received an accidental 3rd dose) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications was not reported. Treatment information were not provided. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), was not applicable.   This case was linked to MOD21-069109 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: No significant information received.; Sender's Comments:  MOD21-069109:
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Sinus headache, Vaccination site pain
Clinical narrative: sinus headache; pain from arm that has metal plate to fingertips; pain at injeciton site; sore arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm), SINUS HEADACHE (sinus headache), PAIN IN EXTREMITY (pain from arm that has metal plate to fingertips) and VACCINATION SITE PAIN (pain at injeciton site) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     The patient's past medical history included Internal fixation of fracture (arm has metal plate).    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), PAIN IN EXTREMITY (pain from arm that has metal plate to fingertips) and VACCINATION SITE PAIN (pain at injeciton site). On 29-Mar-2021, the patient experienced SINUS HEADACHE (sinus headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form and ASPIRIN [ACETYLSALICYLIC ACID] at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (sore arm), SINUS HEADACHE (sinus headache), PAIN IN EXTREMITY (pain from arm that has metal plate to fingertips) and VACCINATION SITE PAIN (pain at injeciton site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment for the event included acetaminophen (Tylenol) and acetylsalicylic acid (Aspirin).
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Chills, Pyrexia
Clinical narrative: bone aches; has very elevated temperatures; chills; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (bone aches), PYREXIA (has very elevated temperatures) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021 at 9:00 PM, the patient experienced BONE PAIN (bone aches), PYREXIA (has very elevated temperatures) and CHILLS (chills). At the time of the report, BONE PAIN (bone aches), PYREXIA (has very elevated temperatures) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided  No treatment medications provided
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Disorientation, Fatigue, Feeling abnormal
Clinical narrative: mild flu; lethargy; cloudy in head; couldn't sleep; sweats; disoriented; joint pain; tiredness; chills; achy; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (mild flu), LETHARGY (lethargy), FEELING ABNORMAL (cloudy in head), INSOMNIA (couldn't sleep) and HYPERHIDROSIS (sweats) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA (mild flu), LETHARGY (lethargy), FEELING ABNORMAL (cloudy in head), INSOMNIA (couldn't sleep), HYPERHIDROSIS (sweats), DISORIENTATION (disoriented), ARTHRALGIA (joint pain), FATIGUE (tiredness), CHILLS (chills) and MYALGIA (achy). At the time of the report, INFLUENZA (mild flu), LETHARGY (lethargy), FEELING ABNORMAL (cloudy in head), INSOMNIA (couldn't sleep), HYPERHIDROSIS (sweats), DISORIENTATION (disoriented), ARTHRALGIA (joint pain), FATIGUE (tiredness), CHILLS (chills) and MYALGIA (achy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-067231 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-067231:crosslinked with dose 1
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Influenza, Insomnia, Lethargy, Myalgia
Clinical narrative: mild flu; lethargy; cloudy in head; couldn't sleep; sweats; disoriented; joint pain; tiredness; chills; achy; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (mild flu), LETHARGY (lethargy), FEELING ABNORMAL (cloudy in head), INSOMNIA (couldn't sleep) and HYPERHIDROSIS (sweats) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA (mild flu), LETHARGY (lethargy), FEELING ABNORMAL (cloudy in head), INSOMNIA (couldn't sleep), HYPERHIDROSIS (sweats), DISORIENTATION (disoriented), ARTHRALGIA (joint pain), FATIGUE (tiredness), CHILLS (chills) and MYALGIA (achy). At the time of the report, INFLUENZA (mild flu), LETHARGY (lethargy), FEELING ABNORMAL (cloudy in head), INSOMNIA (couldn't sleep), HYPERHIDROSIS (sweats), DISORIENTATION (disoriented), ARTHRALGIA (joint pain), FATIGUE (tiredness), CHILLS (chills) and MYALGIA (achy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-067231 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-067231:crosslinked with dose 1
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Pain in extremity, Peripheral swelling, Shoulder injury related to vaccine administration
Clinical narrative: vaccine aggravated the injury and caused the bruise.; she started getting a bruise on her left arm which swelled and was sore; Swelling in her arm; Soreness in her arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (Swelling in her arm), PAIN IN EXTREMITY (Soreness in her arm), CONTUSION (she started getting a bruise on her left arm which swelled and was sore) and SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (vaccine aggravated the injury and caused the bruise.) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included Shoulder injury (One year back) in 2020.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swelling in her arm) and PAIN IN EXTREMITY (Soreness in her arm). On 17-Mar-2021, the patient experienced CONTUSION (she started getting a bruise on her left arm which swelled and was sore). On an unknown date, the patient experienced SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (vaccine aggravated the injury and caused the bruise.). On 12-Mar-2021, PERIPHERAL SWELLING (Swelling in her arm) had resolved, PAIN IN EXTREMITY (Soreness in her arm) outcome was unknown. At the time of the report, CONTUSION (she started getting a bruise on her left arm which swelled and was sore) and SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (vaccine aggravated the injury and caused the bruise.) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided by the reporter. Patient had two therapy appointment between the first dose and the bruise appearing. Treatment medication include the  Ice on that area.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: terribly dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (terribly dizzy) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced DIZZINESS (terribly dizzy). On 24-Feb-2021, DIZZINESS (terribly dizzy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications includes allergies medicines- claridrem (nose, eyes) No treatment medications provided